- Home
- GNS vs FBIO Comparison
GNS vs FBIO Comparison
Compare GNS & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNS
- FBIO
- Stock Information
- Founded
- GNS 2002
- FBIO 2006
- Country
- GNS Singapore
- FBIO United States
- Employees
- GNS N/A
- FBIO N/A
- Industry
- GNS Other Consumer Services
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- GNS Real Estate
- FBIO Health Care
- Exchange
- GNS Nasdaq
- FBIO Nasdaq
- Market Cap
- GNS 81.8M
- FBIO 88.7M
- IPO Year
- GNS 2022
- FBIO N/A
- Fundamental
- Price
- GNS $0.88
- FBIO $2.70
- Analyst Decision
- GNS
- FBIO Strong Buy
- Analyst Count
- GNS 0
- FBIO 2
- Target Price
- GNS N/A
- FBIO $16.50
- AVG Volume (30 Days)
- GNS 1.1M
- FBIO 393.8K
- Earning Date
- GNS 09-23-2025
- FBIO 11-12-2025
- Dividend Yield
- GNS N/A
- FBIO N/A
- EPS Growth
- GNS N/A
- FBIO N/A
- EPS
- GNS N/A
- FBIO N/A
- Revenue
- GNS $5,749,894.00
- FBIO $59,301,000.00
- Revenue This Year
- GNS $82.78
- FBIO $31.85
- Revenue Next Year
- GNS $85.90
- FBIO $44.43
- P/E Ratio
- GNS N/A
- FBIO N/A
- Revenue Growth
- GNS N/A
- FBIO N/A
- 52 Week Low
- GNS $0.21
- FBIO $1.33
- 52 Week High
- GNS $1.92
- FBIO $4.20
- Technical
- Relative Strength Index (RSI)
- GNS 55.59
- FBIO 50.08
- Support Level
- GNS $0.69
- FBIO $2.39
- Resistance Level
- GNS $0.78
- FBIO $2.65
- Average True Range (ATR)
- GNS 0.06
- FBIO 0.12
- MACD
- GNS 0.01
- FBIO 0.03
- Stochastic Oscillator
- GNS 82.84
- FBIO 94.03
About GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education, which involves entrepreneur education, management consultancy, and business development tools; and Campus, consisting of resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America. The company derives maximum revenue from Europe/Middle East/Africa.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.